Table 1 Baseline characteristics who intermediate risk prostate cancer patients with biopsy Gleason score 6 and comparisons according to multi-parametric MRI finding

Number

239

116 (48.5)

123 (51.5)

Mean Age (years, ± SD)

65.79 ± 6.60

65.37 ± 7.15

66.19 ± 6.03

Mean BMI (± SD)

24.49 ± 2.64

24.41 ± 2.75

24.56 ± 2.55

Prostate volume

42.22 ± 18.43

45.27 ± 19.76

39.35 ± 16.65

PSA

13.51 ± 2.82

13.46 ± 2.86

13.56 ± 2.79

Median PSA

12.64

12.32

13.00

Mean PSA density

0.37 ± 0.16

0.36 ± 0.17

0.39 ± 0.15

DM (%)

25 (10.5)

11 (9.5)

14 (11.4)

HTN (%)

113 (47.3)

54 (46.6)

59 (48.0)

Number of biopsy (%)

12

164 (68.6)

80 (69.0)

84 (68.3)

 ≥ 13

75 (31.4)

36 (31.0)

39 (31.7)

Mean percentage of positive core (%, ± SD)

24.44 ± 19.97

20.42 ± 17.09

28.51 ± 21.85

Mean tumor length (mm, ± SD)

0.41 ± 0.34

0.32 ± 0.26

0.51 ± 0.39

Mean percentage of total tumor of core (%, ± SD)

26.47 ± 22.50

20.76 ± 18.05

32.02 ± 24.96

PIRADS score (%)

2

79 (33.1)

79

3

37 (15.5)

37

4

64 (26.8)

64

5

59 (24.7)

59